Bluejay Diagnostics Inc (BJDX) concluded trading on Thursday at a closing price of $2.07, with 3.61 million shares of worth about $7.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.91% during that period and on May 01, 2025 the price saw a gain of about 8.38%. Currently the company’s common shares owned by public are about 0.55M shares, out of which, 0.55M shares are available for trading.
Stock saw a price change of 26.22% in past 5 days and over the past one month there was a price change of -42.82%. Year-to-date (YTD), BJDX shares are showing a performance of -57.49% which decreased to -99.07% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.46 but also hit the highest price of $316.92 during that period. The average intraday trading volume for Bluejay Diagnostics Inc shares is 1.16 million. The stock is currently trading -16.88% below its 20-day simple moving average (SMA20), while that difference is down -38.38% for SMA50 and it goes to -70.91% lower than SMA200.
Bluejay Diagnostics Inc (NASDAQ: BJDX) currently have 0.55M outstanding shares and institutions hold larger chunk of about 0.45% of that.
The stock has a current market capitalization of $3.09M and its 3Y-monthly beta is at 0.40. It has posted earnings per share of -$685.13 in the same period. It has Quick Ratio of 6.05 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BJDX, volatility over the week remained 16.54% while standing at 21.51% over the month.
Analysts are in expectations that Bluejay Diagnostics Inc (BJDX) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
